One notable strategy employed the MUC1-specific 5TR1 aptamer conjugated to DOX-loaded liposomes (PLD), which showed superior antitumor efficacy in murine colorectal cancer models [160]. This evidence concerns the gene MUC1 and colorectal cancer.